Purpose: A meta-analysis of six North Central Cancer Treatment Group (NCCTG
) trials involving patients receiving their first ever fluorouracil (5-FU)-
based chemotherapy was undertaken to explore the association of sex with re
ports of the incidence and severity of stomatitis.
Patients and Methods: Data were obtained on a total of 731 patients (402 me
n and 329 women). Comparisons of incidence and severity rates and average s
tomatitis across sex were performed using standard binomial testing and t t
ests, respectively. Logistic regression analysis and a weighted analysis us
ing data summarized to study level served as evidence of cross-validation,
Results: Women reported stomatitis both more often and with greater severit
y than did men. The incidence of any stomatitis far women was 63% versus 52
% for men (P = .002). The incidence of severe or very severe stomatitis for
men and women was 22% and 12%, respectively (P = .0006), On average, women
reported stomatitis of roughly 0.4 points higher than men on a 0 to 4 ordi
nal scale (P < .00001). Comparison of results across treatment and placebo
arms was carried out to validate the initial findings. Logistic regression
modelling further confirmed the results conditional on the presence of a nu
mber of potentially confounding covariates. Women were also 11% more likely
than men ta experience leukopenia of:common toxicity criteria grade greate
r than or equal to 1, (70% v 59%, respectively; P < .00001) and grade 3 + (
18% v 11%, respectively; P = .004).
Conclusion: More women than men reported 5-FU-induced stomatitis. The preci
se mechanism resulting in different degrees of stomatitis across sex is not
evident. (C) 2000 by American Society of Clinical Oncology.